A glutamatergic basal forebrain to midbrain circuit mediates wakefulness and defensive behavior.

Basal forebrain Defensive behavior Glutaminergic neurons Sleep-wake behavior Ventral tegmental area

Journal

Neuropharmacology
ISSN: 1873-7064
Titre abrégé: Neuropharmacology
Pays: England
ID NLM: 0236217

Informations de publication

Date de publication:
01 05 2022
Historique:
received: 19 08 2021
revised: 29 12 2021
accepted: 30 01 2022
pubmed: 9 2 2022
medline: 15 4 2022
entrez: 8 2 2022
Statut: ppublish

Résumé

Defensive behavior, a group of responses that evolved due to threatening stimuli, is crucial for animal survival in the natural environment. For defensive measures to be timely and successful, a high arousal state and immediate sleep-to-wakefulness transition are required. Recently, the glutamatergic basal forebrain (BF) has been implicated in sleep-wake regulation; however, the associated physiological functions and underlying neural circuits remain unknown. Here, using in vivo fiber photometry, we found that BF glutamatergic neuron is activated by various threatening stimuli, including predator odor, looming threat, sound, and tail suspension. Optogenetic activation of BF glutamatergic neurons induced a series of context-dependent defensive behaviors in mice, including escape, fleeing, avoidance, and hiding. Similar to the effects of activated BF glutamatergic cell body, photoactivation of BF glutamatergic terminals in the ventral tegmental area (VTA) strongly drove defensive behaviors in mice. Using synchronous electroencephalogram (EEG)/electromyogram (EMG) recording, we showed that photoactivation of the glutamatergic BF-VTA pathway produced an immediate transition from sleep to wakefulness and significantly increased wakefulness. Collectively, our results clearly demonstrated that the glutamatergic BF is a key neural substrate involved in wakefulness and defensive behaviors, and encodes these behaviors through glutamatergic BF-VTA pathway. Overexcitation of the glutamatergic BF-VTA pathway may be implicated in clinical psychiatric diseases characterized by exaggerated defensive responses, such as autism spectrum disorders.

Identifiants

pubmed: 35131297
pii: S0028-3908(22)00038-7
doi: 10.1016/j.neuropharm.2022.108979
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108979

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Auteurs

Ping Cai (P)

Fujian Province Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou, 350108, Fujian, China.

Hui-Yun Chen (HY)

Fujian Province Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou, 350108, Fujian, China.

Wei-Tao Tang (WT)

Fujian Province Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou, 350108, Fujian, China.

Yu-Duan Hu (YD)

Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, Fuzhou, 350108, Fujian, China.

Shang-Yi Chen (SY)

Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, Fuzhou, 350108, Fujian, China.

Jing-Shan Lu (JS)

Department of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou, 350108, Fujian, China.

Zhi-Hui Lin (ZH)

Fujian Province Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou, 350108, Fujian, China.

Sheng-Nan Huang (SN)

Fujian Province Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou, 350108, Fujian, China.

Li-Huan Hu (LH)

Department of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou, 350108, Fujian, China.

Wei-Kun Su (WK)

Department of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou, 350108, Fujian, China.

Qi-Xuan Li (QX)

School of Clinical Medicine, Fujian Medical University, Fuzhou, 350108, Fujian, China.

Zhi-Jie Lin (ZJ)

School of Clinical Medicine, Fujian Medical University, Fuzhou, 350108, Fujian, China.

Tian-Rui Kang (TR)

School of Clinical Medicine, Fujian Medical University, Fuzhou, 350108, Fujian, China.

Xiong-Bin Yan (XB)

School of Clinical Medicine, Fujian Medical University, Fuzhou, 350108, Fujian, China.

Pei-Chang Liu (PC)

Department of Anesthesiology, Fujian Medical University Union Hospital, Fuzhou, 350001, Fujian, China.

Li Chen (L)

Department of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou, 350108, Fujian, China; Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, Fuzhou, 350108, Fujian, China.

Dou Yin (D)

Department of Neurology & Institute of Neurology, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.

Si-Ying Wu (SY)

Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, Fuzhou, 350108, Fujian, China.

Huang-Yuan Li (HY)

Fujian Province Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou, 350108, Fujian, China. Electronic address: lhy@fjmu.edu.cn.

Changxi Yu (C)

Department of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou, 350108, Fujian, China; Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, Fuzhou, 350108, Fujian, China. Electronic address: changxiyu@mail.fjmu.edu.cn.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH